$0.80 EPS Expected for STERIS PLC (STE) This Quarter
Equities analysts expect STERIS PLC (NYSE:STE) to report $0.80 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for STERIS PLC’s earnings. The highest EPS estimate is $0.82 and the lowest is $0.79. STERIS PLC reported earnings per share of $0.79 during the same quarter last year, which indicates a positive year-over-year growth rate of 1.3%. The business is scheduled to report its next quarterly earnings report before the market opens on Tuesday, August 8th.
According to Zacks, analysts expect that STERIS PLC will report full-year earnings of $4.06 per share for the current financial year, with EPS estimates ranging from $4.05 to $4.08. For the next fiscal year, analysts forecast that the business will report earnings of $4.53 per share, with EPS estimates ranging from $4.51 to $4.57. Zacks’ EPS calculations are a mean average based on a survey of research analysts that cover STERIS PLC.
STERIS PLC (NYSE:STE) last released its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.05. STERIS PLC had a return on equity of 11.12% and a net margin of 4.20%. The business had revenue of $608 million during the quarter, compared to analyst estimates of $597.66 million. During the same quarter in the previous year, the firm posted $0.79 EPS. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year.
A number of equities analysts have recently issued reports on the company. BidaskClub cut STERIS PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research raised STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a report on Tuesday, July 11th. Wellington Shields cut STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Finally, KeyCorp raised STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 target price for the company in a report on Wednesday, May 3rd. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $84.00.
TRADEMARK VIOLATION WARNING: “$0.80 EPS Expected for STERIS PLC (STE) This Quarter” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/08/08/0-80-eps-expected-for-steris-plc-ste-this-quarter.html.
STERIS PLC (STE) traded up 5.70% on Tuesday, reaching $86.90. The company had a trading volume of 616,796 shares. The stock has a market cap of $7.39 billion, a price-to-earnings ratio of 67.89 and a beta of 1.33. The company has a 50-day moving average of $82.15 and a 200 day moving average of $74.62. STERIS PLC has a one year low of $63.80 and a one year high of $87.49.
In related news, insider Kathleen Bardwell sold 3,795 shares of the stock in a transaction that occurred on Friday, June 16th. The stock was sold at an average price of $82.00, for a total transaction of $311,190.00. Following the sale, the insider now directly owns 20,605 shares in the company, valued at approximately $1,689,610. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $80.05, for a total value of $800,500.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 30,340 shares of company stock worth $2,432,704. 2.55% of the stock is owned by corporate insiders.
Large investors have recently added to or reduced their stakes in the company. Van Cleef Asset Management Inc purchased a new position in STERIS PLC during the second quarter valued at $208,000. Cigna Investments Inc. New purchased a new position in STERIS PLC during the second quarter valued at $209,000. Investment Counselors of Maryland LLC raised its position in STERIS PLC by 28.7% in the first quarter. Investment Counselors of Maryland LLC now owns 2,640 shares of the medical equipment provider’s stock valued at $183,000 after buying an additional 588 shares in the last quarter. Allegis Investment Advisors LLC purchased a new position in STERIS PLC during the second quarter valued at $251,000. Finally, Aureus Asset Management LLC purchased a new position in STERIS PLC during the first quarter valued at $245,000. Institutional investors and hedge funds own 91.80% of the company’s stock.
STERIS PLC Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.